The Relationship Between The Rationality Of Prescribing And The Quality Of Life Of Hypertension Patients At The Central Siantan Health Center In Pontianak
Abstract
Hypertension is a silent killer disease that can affect the patient's quality of life. There is a need for rational treatment to achieve the success of therapy and the desired quality of life. This study aims to determine the relationship between the rationality of prescribing and the quality of life of hypertensive patients. The study design was an observational cohort. Data were obtained from hypertensive patients at the Puskesmas Siantan Tengah Pontianak who met the inclusion criteria in June-July 2021 using a prospective purposive sampling and collected from medical records, EQ5D5L and VAS questionnaires. The results of the study on 101 samples were obtained; the rationality of prescribing antihypertensive drugs was rational, with the percentage of rationality being the appropriate indication 87,12%; appropriate drug 87.12%; appropriate patient 88.11%; and appropriate dose 88.11%. In addition, 28 patients (27.72%) did not have a problem with the five dimensions with the highest EQ5D5L index of 1,000, while the quality of life, as measured by VAS, had a median value of 60. The results of the Pearson chi-square test showed that there was a relationship between the rationality of prescription and quality of life for hypertensive patients with a significance value ≥ 0.05 using the EQ5D5L (p = 0.688) and VAS (p = 0.583) questionnaires. Conclusion: there is no significant relationship between the rationality of prescribing and the quality of life of hypertensive patients, both using the EQ5D5L and VAS questionnaires.
References
E. Y. Sukandar, R. Adrajati, J. I. Sigit, I. K. Adnyana, A. P. Setiadi, and Kusnandar, Iso Farmakoterapi. Chi-Square Tests Value df Asymp. Sig. (2- sided) Exact Sig. (2- sided) Exact Sig. (1-sided) Pearson Chi-Square .301a 1 .583 Jakarta: PT. ISFI Penerbitan, 2008.
E. Triyanto, Pelayanan Keperawatan Bagi Penderita Hipertensi Secara Terpadu. Yogyakarta: Graha Ilmu, 2014.
E. K. R. Sudarsono, J. F. A. Sasmita, A. B. Handyasto, N. Kuswantiningsih, and S. S. Arissaputra, “Peningkatan Pengetahuan Terkait Hipertensi Guna Perbaikan Tekanan Darah pada Pemuda di Dusun Japanan, Margodadi, Seyegan, Sleman, Yogyakarta,” J. Pengabdi. Kpd. Masy. (Indonesian J. Community Engag., vol. 3, no. 1, pp. 26–38,
, doi: 10.22146/jpkm.25944.
A. Yonata and A. S. P. Pratama, “Hipertensi sebagai Faktor Pencetus Terjadinya Stroke,” J. Major., vol. 5, no. 3, pp. 17–21, 2016.
Kementrian Kesehatan RI, Laporan Provinsi Kalimantan Barat RISKESDAS 2018. Kalimantan Barat: Kementrian Kesehatan RI, 2018.
Dinas Kesehatan Kota Pontianak, Profil Kesehatan Kota Pontianak. Kota Pontianak: Dinas Kesehatan Kota Pontianak, 2017.
S. N. Ramadhani, “Studi Literatur : Analisis Faktor Penyebab Tingginya Angka Rujukan di Puskesmas Pada Era JKN,” Media Gizi Kesmas, vol. 9, no. 2, 2020.
S. E. Y. N. Khotimah and L.Musnelina, “Evaluasi Penggunaan Obat Antihipertensi Pada Pasien Hipertensi Primer Usia ≤ 45 Tahun Di Instalasi Rawat Jalan Rumah Sakit Umum Daerah ( RSUD ) Kota Depok,” Sainstech Farma ISSN
-7816, vol. 9, no. 1, pp. 30–34, 2016.
S. Aryzki, N. Aisyah, H. Hutami, and B. Wahyusari, “Evaluasi Rasionalitas Pengobatan Hipertensi Di Puskesmas Pelambuan Banjar Masin Tahun 2017,” J. Ilm. Manuntung, vol. 4, no. 2, p. 119, 2018, doi: 10.51352/jim.v4i2.191.
M. van Reenen et al., EQ-5D : EQ- 5D-5L User Guide. 2019.
A. Sari, N. Yuni Lestari, and D. Aryani Perwitasari, “Validasi ST European Quality OF Life-5 Dimensions (EQ-5D) Versi Indonesia Pada Pasien Hipertensi Di Puskesmas Kotagede II Yogyakarta,” Pharmaciana, vol. 5, no. 2, 2015, doi: 10.12928/pharmaciana.v5i2.2483.
B. Lapau, Metode Penelitian Kesehatan : Metode Ilmiah Penulisan Skripsi, Tesis, dan Disertasi. Jakarta: Yayasan Pustaka Obor Indonesia, 2015.
L. Sundari and M. Bangsawan, “Faktor-Faktor Yang Berhubungan Dengan Kejadian Hipertensi,” J. Keperawatan, vol. 11, no. 2, 2015, doi: 10.36565/jab.v8i1.105.
E. Syahrini, “Faktor-Faktor Risiko Hipertensi Primer Di Puskesmas Tlogosari Kulon Kota Semarang,” J. Kesehat. Masy. Univ. Diponegoro, vol. 1, no. 2, p. 18704, 2012.
T. Taslim and Y. A. Betris, “Gambaran Pemberian Obat pada Penderita Hipertensi di Puskesmas Rawang,” J. Ris. Kefarmasian Indonesia., vol. 2, no. 2, pp. 72–79, 2020.
Nafrialdi, Antihipertensi Dalam Farmakologi dan Terapi Edisi 5. Jakarta: Departemen farmakologi dan Terapeutik, Fakultas Kedokteran Universitas Indonesia, 2008.
A. V. Chobanian et al., “Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and
Treatment of High Blood Pressure,” Hypertension, vol. 42, no. 6, pp. 1206–1252, 2003, doi: 10.1161/01.HYP.0000107251.49515.c2.
U. Sodiqoh, A. Ismunandar, and L.H. Maulana, “Analisis Rasionalitas Penggunaan Obat pada Pasien Hipertensi di Puskesmas Bumiayu Tahun 2021,” Pharm PJ, vol. 1, no. 2, pp. 1–7, 2021.
P. A. James, S. Oparil, B. L. Carter, W. C. Cushman, C. Dennison, and J. Handler, “2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults Report From the Panel Members Appointed to the Eighth Joint National Committee (JNC 8),” vol. 311, no. 5, pp. 507–520, 2014, doi: 10.1001/jama.2013.284427.
S. Alaydrus, “Profil Penggunaan Obat pada pasien Hipertensi di Puskesmas Marawola Periode Januari - Maret 2017,” J. Mandala Pharmacon Indones., vol. 3, no. 2, pp. 110–118, 2017.
D. Darwis, Y. Rikmasari, and W. N. Santi, “Rasionalitas Penggunaan Obat dan Kepatuhan Pasien Hipertensi Di Puskesmas Mekarsari Dan Puskesmas Lebubg Bandung Kabupaten Ogan Ilir Pada Bulan Mei-Juli 2016,” J. Ilm. Bakti Farm., vol. 3, no. 2, pp. 7–18, 2018.
M. A. Yuswar, R. Susanti, and N. S. Az-zahra, “Pengukuran Kualitas Hidup Pasien Pengguna Antihipertensi dengan European Quality of Life 5 Dimensions (EQ5D) Questionnaire dan Visual Analog Scale (VAS) M,” J. Sains Kes, vol. 2, no. 2, pp. 93–99, 2019.
M. A. Yuswar, N. U. Purwanti, and W. Zuraida, “Pengukuran Kualitas Hidup Pasien Hipertensi di Puskesmas Perumnas I Kota Pontianak yang Menggunakan Antihipertensi melalui EQ5D Questionnaire dan VAS,” Pustaka Kesehatan., vol. 7, no. 2, p. 65, 2019, doi: 10.19184/pk.v7i2.19115.
R. A. Farha, A. Saleh, and S. Aburuz, “The impact of drug related problems on health-related quality of life among hypertensive patients in Jordan,” Pharm. Pract. (Granada)., vol. 15, no. 3, pp. 1–8, 2017.
A. Sari, Lolita, and Fauzia, “Puskesmas Mergangsan Yogyakarta Menggunakan Europan Quality of Life 5 Dimensions ( EQ5D ) Questionnaire dan Visual Analog Scale ( VAS ),” J. Ilm. Ibnu Sina, vol. 2, no. 1, pp. 1–12, 2017.